Cargando…
PT-112 induces immunogenic cell death and synergizes with immune checkpoint blockers in mouse tumor models
PT-112 is a novel platinum-pyrophosphate conjugate under clinical development for cancer therapy. PT-112 mediates cytostatic and cytotoxic effects against a variety of human and mouse cancer cell lines in vitro. The cytotoxic response to PT-112 is associated with the emission of danger signals under...
Autores principales: | Yamazaki, Takahiro, Buqué, Aitziber, Ames, Tyler D., Galluzzi, Lorenzo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7028345/ https://www.ncbi.nlm.nih.gov/pubmed/32117585 http://dx.doi.org/10.1080/2162402X.2020.1721810 |
Ejemplares similares
-
PT-112 Induces Mitochondrial Stress and Immunogenic Cell Death, Targeting Tumor Cells with Mitochondrial Deficiencies
por: Soler-Agesta, Ruth, et al.
Publicado: (2022) -
Phase I study of PT-112, a novel pyrophosphate-platinum immunogenic cell death inducer, in advanced solid tumours
por: Karp, Daniel D., et al.
Publicado: (2022) -
Immunofluorescence microscopy-based assessment of cytosolic DNA accumulation in mammalian cells
por: Sato, Ai, et al.
Publicado: (2021) -
NK cells beat T cells at early breast cancer control
por: Buque, Aitziber, et al.
Publicado: (2020) -
Cellular senescence in the response of HR(+) breast cancer to radiotherapy and CDK4/6 inhibitors
por: Klapp, Vanessa, et al.
Publicado: (2023)